FDA has granted Fast Track, Rare Pediatric Disease, and Orphan Drug Designation for EPI-321 in FSHD SOUTH SAN FRANCISCO, CA, USA I August 05, 2025 I Epicrispr Biotechnologies, a clinical-stage company ...